Cargando…
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study
SIMPLE SUMMARY: Giant cell tumors of bone (GCTB) are a histologically benign, yet often aggressive, skeletal tumor. Surgery is the only potentially curative treatment option, but may be associated with severe morbidity and loss of function. Denosumab, a monoclonal antibody directed to RANK ligand, i...
Autores principales: | Palmerini, Emanuela, Pazzaglia, Laura, Cevolani, Luca, Pratelli, Loredana, Pierini, Michela, Quattrini, Irene, Carretta, Elisa, Manara, Maria Cristina, Pasello, Michela, Frega, Giorgio, Paioli, Anna, Longhi, Alessandra, Cesari, Marilena, Hakim, Rossella, Ibrahim, Toni, Campanacci, Laura, Staals, Eric Lodewijk, Donati, Davide Maria, Benassi, Maria Serena, Scotlandi, Katia, Ferrari, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220940/ https://www.ncbi.nlm.nih.gov/pubmed/35740530 http://dx.doi.org/10.3390/cancers14122863 |
Ejemplares similares
-
CD99 at the crossroads of physiology and pathology
por: Pasello, Michela, et al.
Publicado: (2018) -
CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
por: Manara, Maria Cristina, et al.
Publicado: (2018) -
Electrochemotherapy Is Effective in the Treatment of Bone Metastases
por: Campanacci, Laura, et al.
Publicado: (2022) -
Lengthening Patients Previously Treated for Massive Lower Limb Reconstruction for Bone Tumors with the PRECICE 2 Nail
por: Campanacci, Laura, et al.
Publicado: (2023) -
Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results
por: Palmerini, Emanuela, et al.
Publicado: (2018)